Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ATP6 pseudogene 14 (MTATP6P14) is a pseudogene sequence related to the functional mitochondrial gene MT-ATP6, which encodes a subunit of mitochondrial ATP synthase (Complex V). Unlike the functional MT-ATP6 gene, which plays a critical role in the mitochondrial production of ATP, MTATP6P14 is not known to be transcribed or translated into a functional protein and has no established biological or clinical role. It is not considered a drug target and has no current associations with disease, pharmacology, or biomarker utility. Clinical significance and therapeutic targeting relate exclusively to the active MT-ATP6 gene, not this pseudogene[1][2][3][4][5].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ATP6 pseudogene 14 (MTATP6P14).